Founded
31 Dec 1998
Website
VCID: 127463
Profile
Corporate information
Official name
Illumina Incorporated
Registration country
Official name
Illumina Incorporated
Registration country
Investment activity status
Active investor
Company type
Developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function.Funding
Funding rounds
(31 Dec 1998)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Venrock Associates | The venture capital arm of the Rockefeller Family. | United States |
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
ARCH Venture Partners LP | Venture capital firm providing seed and early stage capital, with a special expertise in co-founding and building technology firms from startup | United States | |
|
BayStar Capital | |||
|
Celera Corp | A healthcare company dedicated at first on sequencing human genome; now focused on therapeutics for cancer and other diseases | United States | |
|
Chevron Technology Ventures LLC | Corporate venturing subsidiary of ChevronTexaco, focusing on the commercialisation and integration of emerging technologies within Chevron | United States | |
|
Comdisco Inc | United States | ||
|
|
CW Group Inc | United States | ||
|
Dow Venture Capital | The corporate venture capital unit of Dow Chemical Co | United States | |
|
JPMorgan Chase & Co | United States | ||
|
Oxford Bioscience Partners III LP | United States | ||
|
|
Roche Holding Ltd |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
ARCH Venture Partners LP Venture capital firm providing seed and early stage capital, with a special expertise in co-founding and building technology firms from startup |
+1 (415) 565-7103 |
N/A |
|
|
BayStar Capital |
N/A | |
|
|
Celera Corp A healthcare company dedicated at first on sequencing human genome; now focused on therapeutics for cancer and other diseases |
N/A | |
|
|
Chevron Technology Ventures LLC Corporate venturing subsidiary of ChevronTexaco, focusing on the commercialisation and integration of emerging technologies within Chevron |
+1 (713) 954-6974 |
N/A |
|
|
Comdisco Inc |
N/A | |
|
|
CW Group Inc |
+1 (202) 508-1040 |
N/A |
|
|
Dow Venture Capital The corporate venture capital unit of Dow Chemical Co |
+1 (989) 636-5692 |
N/A |
|
|
JPMorgan Chase & Co |
N/A | |
|
|
Oxford Bioscience Partners III LP |
N/A | |
|
|
Roche Holding Ltd |
N/A | |
|
|
Venrock Associates The venture capital arm of the Rockefeller Family. |
+1 (617) 995-2000 |
N/A |
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
|
Illumina Ventures I |
31 Dec 2018 | Fund Closing Active |
||
|
Oxford Nanopore Technologies Ltd Developing the GridION system, a new generation of technology that uses nanopores - very small holes created in electrically resistant membranes. |
United Kingdom | 26 Apr 2011 | Venture Exited |
|
|
|
Helixis Inc Medical equipment company that develops low-cost molecular diagnostic products. |
United States | 30 Apr 2010 | Acquisition USD 105,000,000 (USD 105,000,000) deal size. Active |
|
|
|
Nextbio |
United States | Acquisition Led the investment round. Active |
||
|
|
Avantome |
Acquisition Initial investment. Led the investment round. Active |